FDA QMSR 2026: What Medical Device Manufacturers Need to Know

For medical-device manufacturers, 2026 brings practical regulatory changes that should be translated into clear actions across quality, regulatory and operational teams.

A major change is now in effect

On February 2, 2026, FDA’s Quality Management System Regulation (QMSR) became effective. The revised 21 CFR Part 820 incorporates ISO 13485:2016 by reference and is intended to more closely align the U.S. medical-device quality framework with internationally recognized quality-management requirements.

What changed for manufacturers

The transition is more than a terminology update. Manufacturers should ensure that their quality management system is structured to meet the QMSR requirements together with other applicable FDA requirements. Companies that already operate an ISO 13485-certified QMS may have a strong foundation, but certification alone does not establish FDA compliance. U.S.-specific regulatory obligations still need to be addressed within procedures, records and day-to-day execution.

Records require particular attention

FDA has clarified that investigators may review QMS records created before the QMSR effective date when assessing compliance. The agency may also inspect records such as management review, quality audit and supplier audit reports that previously benefited from specific inspection exemptions under the former Quality System Regulation. This makes record completeness, consistency and traceability especially important.

Practical actions to take now

Manufacturers should perform a documented gap assessment between their existing system and the QMSR framework; update procedures and terminology where necessary; verify that U.S.-specific requirements are integrated into the QMS; assess supplier, complaint, CAPA, design and risk-management processes; confirm management-review and audit records are inspection-ready; and train relevant personnel on the new FDA expectations.

The compliance objective

The strongest approach is not simply to “convert” old procedures. Organizations should demonstrate that their QMS is implemented, effective and supported by objective evidence. A well-integrated system can reduce duplication between U.S. and international quality requirements while improving inspection readiness and operational consistency.